PTMScan® Lactyl Lysine Motif (K-La) Kit #83284
Additional Information
This product is intended for peptide enrichment and mass spectrometry analysis. To learn more about our Proteomics Kits and Services please answer a few questions for our Proteomics group.
Product Information
Storage
实验步骤
Product Description
Background
Lactyl lysine exists as two stereoisomers: KL-la and KD-la, though the chief form in mammalian cells is the L stereoisomer KL-la (S configuration). EP300 and KAT2A are among the known enzymes that utilize lactyl-coenzyme A (lactyl-CoA) to lactylate proteins, while SIRT3 and HDAC1 have been documented to remove lactylation (3,4). These enzymes regulate other lysine acyl PTMs, most notably lysine acetylation. However, the regulatory pathways of lactylation differ in several aspects from analogous pathways of acetylation. For example, ACSS2 converts lactate into lactyl-CoA through a cascade of ERK signaling and PIN2 isomerization. While ACSS2 can similarly process acetate into lactyl-CoA, the ACSS2 residues responsible for binding differ from the residues for binding lactate (5). In another example, AARS1 can directly conjugate lactate to proteins without generating a lactyl-CoA donor (6).
Lactate is involved in diverse biological contexts, such as accumulation in brain tissue during cerebral ischemia-reperfusion injury and aerobic glycolysis in cancer. Lactylation roles are likely equally diverse and potentially distinct from acetylation (7). Interestingly, few domains that otherwise bind acetylated lysines have been found to bind lactylated lysines. One known lactyl lysine binder is TRIM33, where a conserved glutamate within the TRIM33 bromodomain is necessary and sufficient for binding to lactylated histones, yet does not affect binding to acetylated histones (8). Differentiating the unique regulation and impact of lactylation from other acyl PTMs remains an active and important area of research.
- Zhang, D. et al. (2019) Nature 574, 575-580.
- Bao, Q. et al. (2024) J Am Soc Mass Spectrom 35, 3221-3232.
- Moreno-Yruela, C. et al. (2022) Sci Adv 8, eabi6696.
- Fan, Z. et al. (2023) iScience 26, 107757.
- Zhu, R. et al. (2025) Cell Metab 37, 361-376.e7.
- Ju, J. et al. (2024) J Clin Invest 134, e174587. doi: 10.1172/JCI174587.
- Shi, P. et al. (2025) Front Cell Dev Biol 13, 1535611.
- Nuñez, R. et al. (2024) ACS Chem Biol 19, 2418-2428.
限制使用
除非 CST 的合法授书代表以书面形式书行明确同意,否书以下条款适用于 CST、其关书方或分书商提供的书品。 任何书充本条款或与本条款不同的客书条款和条件,除非书 CST 的合法授书代表以书面形式书独接受, 否书均被拒书,并且无效。
专品专有“专供研究使用”的专专或专似的专专声明, 且未专得美国食品和专品管理局或其他外国或国内专管机专专专任何用途的批准、准专或专可。客专不得将任何专品用于任何专断或治专目的, 或以任何不符合专专声明的方式使用专品。CST 专售或专可的专品提供专作专最专用专的客专,且专用于研专用途。将专品用于专断、专防或治专目的, 或专专售(专独或作专专成)或其他商专目的而专专专品,均需要 CST 的专独专可。客专:(a) 不得专独或与其他材料专合向任何第三方出售、专可、 出借、捐专或以其他方式专专或提供任何专品,或使用专品制造任何商专专品,(b) 不得复制、修改、逆向工程、反专专、 反专专专品或以其他方式专专专专专品的基专专专或技专,或使用专品开专任何与 CST 的专品或服专专争的专品或服专, (c) 不得更改或专除专品上的任何商专、商品名称、徽专、专利或版专声明或专专,(d) 只能根据 CST 的专品专售条款和任何适用文档使用专品, (e) 专遵守客专与专品一起使用的任何第三方专品或服专的任何专可、服专条款或专似专专